相关实验视频
Updated: Jul 19, 2025

04:45
Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice
Published on: May 5, 2022
2.5K
在COVID-19疫苗接种后运动员的心脏后果:证据和错误信息
Joelle Julius Nicolaas Daems1, Juliette C van Hattum2, Sjoerd M Verwijs2
1Cardiology, Amsterdam University Medical Centres, Amsterdam, The Netherlands jjndaems@gmail.com.
British journal of sports medicine
|August 10, 2023
概括
COVID-19 mRNA疫苗对运动员来说是安全的,没有证据表明心脏风险增加. 虽然存在罕见的心肌炎病例 (C-VAM),但运动员在接种疫苗后的发病率很低,没有报告的心脏并发症.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 运动医学 运动医学
背景情况:
- 接种SARS-CoV-2mRNA疫苗后的心肌炎是一个罕见的问题,特别是在运动员中.
- 针对COVID-19 mRNA疫苗接种相关心肌炎 (C-VAM) 的拟议机制涉及免疫系统激活和分子模拟.
研究的目的:
- 评估COVID-19 mRNA疫苗接种在运动员中的安全性和心脏影响.
- 为了解决有关年轻运动员群体潜在风险增加的担忧.
主要方法:
- 40岁以下个体的子组分析.
- 在运动员接种疫苗后报告的心脏并发症和副作用的审查.
- 对将mRNA疫苗接种与运动员突然心脏骤停/死亡 (SCA/D) 联系起来的说法的分析.
主要成果:
- 与SARS-CoV-2感染相比,在mRNA疫苗接种后40岁以下的人群中心肌炎的发病率较低.
- 没有确认运动员患有心脏并发症或SCA/D的确诊病例,归因于mRNA疫苗接种.
- 大多数运动员报告的轻微副作用;在一些强剂后,最大氧气消耗略有下降.
结论:
- 目前的证据不支持由于COVID-19mRNA疫苗接种导致运动员心肌连续症或SCA/D风险增加的说法.
- 虽然C-VAM很少见,但可以考虑疫苗方案的选择和时间,以防止潜在的性能影响.
更多相关视频
相关概念视频
Exercise and Cardiovascular Response
866
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
866
Myocarditis III: Medical Management
9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Myocarditis II: Clinical Features and Diagnostic Tests
12
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Myocarditis I: Introduction
9
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
9
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy V: Interprofessional Care
16
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16

